Location of Repository

Angiopoietin-like protein 2 sensitively responds to weight reduction induced by lifestyle intervention on overweight Japanese men

By A Muramoto, K Tsushita, A Kato, N Ozaki, M Tabata, M Endo, Y Oike and Y Oiso
Topics: Original Article
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:3302127
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2011). Adipokines in inflammation and metabolic disease. Nat Rev Immunol
    2. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes
    3. (2009). Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab
    4. (2009). Angiopoietin-like proteins-potential therapeutic targets for metabolic syndrome and cardiovascular disease.
    5. (2001). Assessment of human body composition using dual-energy x-ray absorptiometry and bioelectrical impedance analysis. Med Sci Monit
    6. (1993). Body weight and mortality. A 27-year follow-up of middle-aged men.
    7. (2002). C-reactive protein predicts death in patients with previous premature myocardial infarction-a 10 year follow-up study. Atherosclerosis
    8. (2010). Changes in C-reactive protein during weight loss and the association with changes in anthropometric variables in men and women: LIFE Study. Int J Obes (Lond)
    9. Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes
    10. (2000). Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation
    11. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
    12. (2003). Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA
    13. (2001). Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol
    14. (2003). Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol
    15. (2002). Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes
    16. (2003). Lindga ¨rde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes
    17. Lindga ¨rde F. Prevention of type 2 (non-insulindependent) diabetes mellitus by diet and physical exercise.
    18. (2001). Prevalence of obesity, diabetes, and obesity-related health risk factors,
    19. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
    20. (2004). Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care
    21. (2010). Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int
    22. (1994). Syndrome X: 6 years later.
    23. (2010). Synoviocyte-derived Angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis.
    24. (2001). The association of c-reactive protein, serum amyloid a and fibrinogen Angptl2 vs weight reduction A Muramoto et al Nutrition and Diabeteswith prevalent coronary heart disease-baseline findings of the PAIS project. Atherosclerosis
    25. (1998). The effect of age on the association between body-mass index and mortality.
    26. (2002). The Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘obesity disease’. Japan Circ J
    27. (1997). The homeostasis model in the San Antonio Heart Study. Diabetes Care
    28. (2005). The metabolic syndrome. Lancet
    29. (2004). Use and abuse of HOMA modeling. Diabetes Care
    30. (2008). Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study.
    31. (1991). year Malmo ¨ feasibility study. Diabetologia

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.